Peter Kim | |
|---|---|
 | |
| Born | April 27, 1958 |
| Alma mater | Cornell University (BA) Stanford University (PhD) |
| Known for | Discovering how proteins cause viral membranes to fuse with cells. |
| Awards | Member of the National Academy of Sciences (1997)[1] Member of National Academy of Medicine (2000)[2] Member of the National Academy of Engineering (2016)[3] |
| Scientific career | |
| Institutions | Massachusetts Institute of Technology Merck & Co., Inc. Stanford University |
| Thesis | Characterization of protein folding intermediates (1985) |
| Doctoral advisor | Robert L. Baldwin |
| Website | peterkimlab |
Peter S. Kim (born April 27, 1958) is an American scientist. He was president of Merck Research Laboratories (MRL) 2003–2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.[4][5][6][7]
In 2016, Kim was elected a member of the National Academy of Engineering for leadership in the discovery and development of novel drugs and vaccines used worldwide.
- ^ "Peter Kim". National Academy of Sciences Member Directory.
- ^ "Peter Kim". National Academy of Medicine Member Directory.
- ^ "Peter Kim". National Academy of Engineering Member Directory.
- ^ "MERCK RESEARCH LABS CHIEF PETER KIM TO JOIN STANFORD'S DEPARTMENT OF BIOCHEMISTRY". Stanford Engineering. December 13, 2013. Retrieved January 27, 2014.
- ^ "Institute Scholars | ChEM-H". chemh.stanford.edu. Retrieved February 5, 2019.
- ^ "CZ Biohub Scientific Leadership – Chan Zuckerberg Biohub". Retrieved February 5, 2019.
- ^ University, Stanford (October 26, 2016). "Biochemist Peter Kim leads Chan Zuckerberg Biohub project". Stanford News. Retrieved February 20, 2019.